Aprotinin in aortic surgery requiring profound hypothermia and circulatory arrest

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 2, 1997, Pages 373-378

  Rooney, Stephen J ^a   Pagano, Domenico ^a   Bognolo, Giulio ^a   Wong, Carl ^a   Bonser, Robert S ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Aortic surgery; Aprotinin; Circulatory arrest; Hypothermia

Indexed keywords

APROTININ;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ARREST; HEMOSTASIS; HUMAN; HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; STROKE; THROMBOSIS; VASCULAR SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANEURYSM, DISSECTING; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; AORTIC DISEASES; APROTININ; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART ARREST, INDUCED; HEMOSTATICS; HUMANS; HYPOTHERMIA, INDUCED; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0031019780     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)01033-0     Document Type: Article

References (21)

1. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-72.
2. Bidstrup BP, Royston D, McGuinness C, Sapsford RN. Aprotinin in aspirin-pretreated patients. Perfusion 1990;5:77-81.
3. Dietrich W, Mossinger H, Spannagl M, Jochum M, Wendt P, Barankay A, Meisner H, Richter JA. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg 1993;105:712-20.
4. Elliott MJ, Allen A. Aprotinin in paediatric cardiac surgery. Perfusion 1990;5:73-6.
5. Espana S, Estelles A, Griffin JH, Aznar J, Gilabert J. Aprotinin (Trasylol) is a competitive inhibitor of activated protein C. Thromb Res 1989;56:751-6.
6. Goldstein DJ, Seldomridge A, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, Smith CR, Rose EA, Levin HR, Oz MC. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg 1995;59:1063-8.
7. Harder MP, Eijsman L, Roozendaal KJ, van Oeveren W, Wildevuur CRH. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann Thorac Surg 1991;51:936-41.
8. Kesten S, de Hoyas A, Chaparro C, Westney G, Winton T, Maurer JR. Aprotinin reduces blood loss in lung transplant patients. Ann Thorac Surg 1995;59:877-9.
9. Krian A. Incidence, prevention and treatment of acute renal failure following cardiopulmonary bypass. Int Anesthesiol Clin 1976;14:87-101.
10. Kurrek MM, Reed RL. Effect of hypothermia on enzymatic activity of thrombin and plasmin. Surg Forum 1987;38:221-3.
11. Mohr R, Golan M, Martinowitz U, Rosner E, Goor DA. Effect of cardiac operation on platelets. J Thorac Cardiovasc Surg 1986;92:434-41.
12. Murkin JM, Lux J, Shannon NA, Guiraudon GM, Menkis AH, McKenzie FN, Novick RJ. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994;107:554-61.
13. Musial J, Niewiarowski S, Hershock D, Morinelli TA, Colman RW, Edmunds Jr LH. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med 1985;105:514-22.
14. Pagano D, Carey JA, Patel RL, Allen SM, Tsang GMK, Hutton P, Lilley JP, Faroqui MH, Bonser RS. Retrograde cerebral perfusion: clinical experience in emergency and elective operations. Ann Thorac Surg 1995;59:1-5.
15. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987;2:1289-91.
16. Sundt TM, Kouchoukos NT, Saffitz JE, Murphy SF, Wareing TH, Stahl DJ. Renal dysfunction and intravascular coagulation with aprotinin and hypothermie circulatory arrest. Ann Thorac Surg 1993;55:1418-24.
17. van Oeveren W, Jansen NJ, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CRH. Effects of aprotinin on haemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 1987;44:640-5.
18. van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
19. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989;97:235-9.
20. Westaby S. Aprotinin in perspective. Ann Thorac Surg 1993;55:1033-41.
21. Westaby S, Forni A, Dunning J, Giannopoulos N, O'Regan D, Drossos G, Pillai R. Aprotinin and bleeding in profoundly hypothermie perfusion. Eur J Cardiothorac Surg 1994;8:82-6.